Life-threatening pustular and erythrodermic psoriasis responding to infliximab.

Thomas G. Lewis; Chanisada Tuchinda; Henry W. Lim; Henry K. Wong

Life-threatening pustular and erythrodermic psoriasis responding to infliximab.

Thomas G. Lewis
, Chanisada Tuchinda
, Henry W. Lim
, Henry K. Wong

Henry Ford Hospital

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

Abstract

Pustular and erythrodermic psoriasis can be a debilitating and recalcitrant disease which may result in secondary complications such as sepsis, electrolyte imbalance, renal failure, and heart failure. We report a case of a 46-year-old patient with life-threatening erythrodermic psoriasis who responded rapidly to intravenous infliximab.

Original language	English
Pages (from-to)	546-548
Number of pages	3
Journal	Journal of Drugs in Dermatology
Volume	5
Issue number	6
Publication status	Published - Jun 2006
Externally published	Yes

Cite this

@article{aac0e8a2dcdb4a478e285cef7d9f36ce,

title = "Life-threatening pustular and erythrodermic psoriasis responding to infliximab.",

abstract = "Pustular and erythrodermic psoriasis can be a debilitating and recalcitrant disease which may result in secondary complications such as sepsis, electrolyte imbalance, renal failure, and heart failure. We report a case of a 46-year-old patient with life-threatening erythrodermic psoriasis who responded rapidly to intravenous infliximab.",

author = "Lewis, \{Thomas G.\} and Chanisada Tuchinda and Lim, \{Henry W.\} and Wong, \{Henry K.\}",

year = "2006",

month = jun,

language = "English",

volume = "5",

pages = "546--548",

journal = "Journal of Drugs in Dermatology",

issn = "1545-9616",

publisher = "Journal of Drugs in Dermatology",

number = "6",

}

TY - JOUR

T1 - Life-threatening pustular and erythrodermic psoriasis responding to infliximab.

AU - Lewis, Thomas G.

AU - Tuchinda, Chanisada

AU - Lim, Henry W.

AU - Wong, Henry K.

PY - 2006/6

Y1 - 2006/6

N2 - Pustular and erythrodermic psoriasis can be a debilitating and recalcitrant disease which may result in secondary complications such as sepsis, electrolyte imbalance, renal failure, and heart failure. We report a case of a 46-year-old patient with life-threatening erythrodermic psoriasis who responded rapidly to intravenous infliximab.

AB - Pustular and erythrodermic psoriasis can be a debilitating and recalcitrant disease which may result in secondary complications such as sepsis, electrolyte imbalance, renal failure, and heart failure. We report a case of a 46-year-old patient with life-threatening erythrodermic psoriasis who responded rapidly to intravenous infliximab.

UR - https://www.scopus.com/pages/publications/33746443001

M3 - Article

C2 - 16774108

AN - SCOPUS:33746443001

SN - 1545-9616

VL - 5

SP - 546

EP - 548

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

IS - 6

ER -

Life-threatening pustular and erythrodermic psoriasis responding to infliximab.

Abstract

Other files and links

Fingerprint

Cite this